Brought to you by 
Ixchelsis raises $14mm through Series A
14 Aug 2013
Executive Summary
Ixchelsis Ltd. (male sexual health therapeutics) has raised over $14mm in its Series A venture round. TVM Capital, through its TVM Life Sciences Ventures VII fund, was the sole investor and one of the VC’s directors will take a seat on the company’s board. The money will be distributed in several tranches.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ixchelsis raises $14mm through Series A
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice